There were 1,830 press releases posted in the last 24 hours and 442,595 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Crinetics Pharmaceuticals Advances CRN04777 for Congenital Hyperinsulinism into Phase 1 Study

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image